CB1 Cannabinoid Receptor Activation Rescues Amyloid β-Induced Alterations in Behaviour and Intrinsic Electrophysiological Properties of Rat Hippocampal CA1 Pyramidal Neurones

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cellular Physiology and Biochemistry

• Publication date

  2012-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1159/000338494PMID 22508047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring.

  2011cited by this paper
• Spatial learning deficits in mice lacking A‐type K+ channel subunits

  2011cited by this paper
• Computational Study of Hippocampal-Septal Theta Rhythm Changes Due to Beta-Amyloid-Altered Ionic Channels

  2011cited by this paper
• PROCESSING OF THE AMYLOID PRECURSOR PROTEIN GENERATES Aβ PEPTIDES

  2010cited by this paper
• Apoptosis Inhibition Can Be Threatening in Aβ-Induced Neuroinflammation, Through Promoting Cell Proliferation

  2010cited by this paper
• Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin?

  2010cited by this paper
• Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats.

  2010cited by this paper
• Dendritic Cell Regulation by Cannabinoid-Based Drugs

  2010cited by this paper
• PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila

  2010cited by this paper
• Different electrophysiological actions of 24- and 72-hour aggregated amyloid-beta oligomers on hippocampal field population spike in both anesthetized and awake rats.

  2010cited by this paper
• Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

  2010cited by this paper
• Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy

  2009cited by this paper
• Opposite Effects of Low and High Doses of Aβ42 on Electrical Network and Neuronal Excitability in the Rat Prefrontal Cortex

  2009cited by this paper
• The Contribution of Synaptic Inputs to Sustained Depolarizations in Reticulospinal Neurons

  2009cited by this paper
• Dysregulation of Calcium Homeostasis in Alzheimer’s Disease

  2009cited by this paper
• Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

  2009cited by this paper
• Cannabinoids Affect Dendritic Cell (DC) Potassium Channel Function and Modulate DC T Cell Stimulatory Capacity1

  2008cited by this paper
• Aβ Oligomers – a decade of discovery

  2007cited by this paper
• Alterations in intrinsic neuronal excitability during normal aging

  2007cited by this paper
• Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

  2007cited by this paper
• Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

  2007cited by this paper
• Cannabinoids and Neuroprotection in Basal Ganglia Disorders

  2007cited by this paper
• Opposing Control of Cannabinoid Receptor Stimulation on Amyloid-β-Induced Reactive Gliosis: In Vitro and in Vivo Evidence

  2007cited by this paper
• The seek of neuroprotection: introducing cannabinoids.

  2007cited by this paper
• Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.

  2007cited by this paper
• Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels

  2006cited by this paper
• Current pharmacotherapy for Alzheimer's disease.

  2006cited by this paper
• Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids.

  2006cited by this paper
• Amyloid β peptide as a physiological modulator of neuronal ‘A’-type K+ current

  2006cited by this paper
• Current Pharmacotherapy for Alzheimer ’ s Disease

  2006cited by this paper
• Amyloid-beta1-42 reduces neuronal excitability in mouse dentate gyrus.

  2006cited by this paper
• Effects of lipids and aging on the neurotoxicity and neuronal loss caused by intracerebral injections of the amyloid-beta peptide in the rat.

  2006cited by this paper
• Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.

  2006cited by this paper
• Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current.

  2006cited by this paper
• Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation.

  2005cited by this paper
• Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.

  2005cited by this paper
• Kv4 potassium channel subunits control action potential repolarization and frequency‐dependent broadening in rat hippocampal CA1 pyramidal neurones

  2005cited by this paper
• Amyloid beta peptide-induced cholinergic fibres loss in the cerebral cortex of the rat is modified by diet high in lipids and by age.

  2005cited by this paper
• Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals.

  2005cited by this paper
• Kv 4 potassium channel subunits control action potential repolarization and frequency-dependent broadening in rat hippocampal CA 1 pyramidal neurones

  2005cited by this paper
• Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.

  2005cited by this paper
• Pathways towards and away from Alzheimer's disease

  2004cited by this paper
• Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.

  2004cited by this paper
• β-Amyloid Peptide at Sublethal Concentrations Downregulates Brain-Derived Neurotrophic Factor Functions in Cultured Cortical Neurons

  2004cited by this paper
• LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites

  2004cited by this paper
• Amyloid Beta Peptide‐Induced Cerebral Neuronal Loss Is Mediated By Caspase‐3 In Vivo

  2004cited by this paper
• Synaptic plasticity in animal models of early Alzheimer's disease.

  2003cited by this paper
• Propofol facilitates the development of long-term depression (LTD) and impairs the maintenance of long-term potentiation (LTP) in the CA1 region of the hippocampus of anesthetized rats.

  2002cited by this paper
• Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

  2002cited by this paper
• Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• SHORT COMMUNICATION Learning‐induced reduction in post‐burst after‐hyperpolarization (AHP) is mediated by activation of PKC

  2002cited by this paper
• Control of Ca2+ influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K+ channels

  2001cited by this paper
• Beta-amyloid, neuronal death and Alzheimer's disease.

  2001cited by this paper
• Modulation of Excitability by α-Dendrotoxin-Sensitive Potassium Channels in Neocortical Pyramidal Neurons

  2001cited by this paper
• Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta(1-42)) abolishes calcium influx via N-type calcium channels.

  2001cited by this paper
• CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.

  2001cited by this paper
• Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity.

  2001cited by this paper
• Differential effects of unaggregated and aggregated amyloid β protein (1–40) on K+ channel currents in primary cultures of rat cerebellar granule and cortical neurones

  2001cited by this paper
• Direct inhibition of T‐type calcium channels by the endogenous cannabinoid anandamide

  2001cited by this paper
• Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease.

  2001cited by this paper
• Involvement of the rat prefrontal cortex in cognitive functions: A central role for the prelimbic area

  2000cited by this paper
• Cellular Mechanisms of Long-Lasting Adaptation in Visual Cortical Neurons In Vitro

  2000cited by this paper
• Cell death or synaptic loss in Alzheimer disease.

  2000cited by this paper
• β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis

  2000cited by this paper
• Hippocampo‐prefrontal cortex pathway: Anatomical and electrophysiological characteristics

  2000cited by this paper
• β-Amyloid-induced activation of Caspase-3 in primary cultures of rat neurons

  2000cited by this paper
• Synaptic Control Of Motoneuron Excitability In Rodents: From Months To Milliseconds

  2000cited by this paper
• The effects of separate and combined perirhinal and prefrontal cortex lesions on spatial memory tasks in the rat

  2000cited by this paper
• Amyloid diseases: abnormal protein aggregation in neurodegeneration.

  1999cited by this paper
• The role of BK‐type Ca2+‐dependent K+ channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells

  1999cited by this paper
• Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

  1999cited by this paper
• Long-lasting increase in cellular excitability associated with the priming of LTP induction in rat hippocampus.

  1999cited by this paper
• Improvement by nefiracetam of β‐amyloid‐(1‐42)‐induced learning and memory impairments in rats

  1999cited by this paper
• Amyloid beta protein increases Ca2+ currents in rat cerebellar granule neurones.

  1998cited by this paper
• Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

  1998cited by this paper
• Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.

  1997cited by this paper
• Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons.

  1997cited by this paper
• Amyloid β Protein Potentiates Ca2+ Influx Through L‐Type Voltage‐Sensitive Ca2+ Channels: A Possible Involvement of Free Radicals

  1997cited by this paper
• Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.

  1996cited by this paper
• Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures

  1996cited by this paper
• Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein

  1996cited by this paper
• Memory and the Prefrontal Cortex a

  1995cited by this paper
• Architecture of the Prefrontal Cortex and the Central Executive

  1995cited by this paper
• Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells

  1994cited by this paper
• Working memory, response selection, and effortful processing in rats with medial prefrontal lesions.

  1994cited by this paper
• Frontal lobes and behaviour.

  1994cited by this paper
• Neuropharmacology of quinolinic and kynurenic acids.

  1993cited by this paper
• Multiple mechanisms of picrotoxin block of GABA‐induced currents in rat hippocampal neurons.

  1993cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper
• Potassium currents in hippocampal pyramidal cells.

  1990cited by this paper
• Action potential repolarization and a fast after‐hyperpolarization in rat hippocampal pyramidal cells.

  1987cited by this paper
• A direct projection from Ammon's horn to prefrontal cortex in the rat.

  1981cited by this paper
• Biophysical mechanisms contributing to inking behavior in Aplysia.

  1979cited by this paper
• Article Title: Cellular Excitability and the Regulation of Functional Neuronal Identity: from Gene Expression to Neuromodulation

  year unknowncited by this paper

• The Role of Endocannabinoids in Physiological Processes and Disease Pathology: A Comprehensive Review

  2025cites this paper
• The role of LINGO-1 in regulating CB1R/TrkB signalling and GABAergic interneurons in Alzheimer's disease pathogenesis.

  2025cites this paper
• Restoring neuronal excitability and spatial memory through inhibiting amyloid-β-induced hyperactive NF-κB in a rat model of Alzheimer's disease.

  2025cites this paper
• The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex® - A Cannabis-derived Spray.

  2024cites this paper
• Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review

  2024cites this paper
• Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease

  2024cites this paper
• Deleterious and protective effects of epothilone-D alone and in the context of amyloid β- and tau-induced alterations

  2023cites this paper
• Neuroprotective Effects of Ferrostatin and Necrostatin Against Entorhinal Amyloidopathy-Induced Electrophysiological Alterations Mediated by voltage-gated Ca^2+ Channels in the Dentate Gyrus Granular Cells

  2023cites this paper
• Δ8-THC Protects against Amyloid Beta Toxicity Modulating ER Stress In Vitro: A Transcriptomic Analysis

  2023cites this paper
• Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review

  2023cites this paper
• A network pharmacology approach to explore pharmacological mechanisms of Asparagus racemosus for ameliorative effect in epilepsy and comorbid progressive memory dysfunction

  2023cites this paper
• Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP

  2023cites this paper
• Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

  2023cites this paper
• Gene Expression Analysis of the Endocannabinoid System in Presymptomatic APP/PS1 Mice

  2022cites this paper
• Kisspeptin-13 prevented the electrophysiological alterations induced by Amyloid-Beta pathology in rat: Possible involvement of stromal interaction molecules and pCREB.

  2022cites this paper
• Cellular and molecular mechanisms of stress-induced memory impairment

  2022cites this paper
• Probable role of the hyperpolarization-activated current in the dual effects of CB1R antagonism on behaviors in a Parkinsonism mouse model.

  2022cites this paper
• An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer’s Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model

  2022cites this paper
• Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease

  2022influential citation
• The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?

  2021cites this paper
• Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies.

  2021cites this paper
• Dietary phytochemicals that influence gut microbiota: Roles and actions as anti-Alzheimer agents

  2021cites this paper
• The Effects and Mechanisms of Phytochemicals on Alzheimer’s Disease Neuropathology

  2021cites this paper
• Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?

  2021cites this paper
• Dementia: Alzheimer’s Disease

  2021cites this paper
• Activation of PLCβ1 enhances endocannabinoid mobilization to restore hippocampal spike-timing-dependent potentiation and contextual fear memory impaired by Alzheimer’s amyloidosis

  2021cites this paper
• An ultra-low dose of Δ9-tetrahydrocannabinol improves Alzheimer’s Disease-related cognitive deficits

  2021cites this paper
• Treatment with edaravone improves the structure and functional changes in the hippocampus after chronic cerebral hypoperfusion in rat.

  2021cites this paper
• Ceftriaxone improves senile neurocognition damages induced by D-galactose in mice

  2020cites this paper
• An Intensified Acrolein Exposure Can Affect Memory and Cognition in Rat

  2020cites this paper
• Genetic Variation and Sex Mediate Differential Responses to ∆-9-tetrahydrocannabinol among Inbred Mice

  2020cites this paper
• Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.

  2020cites this paper
• Auraptene has neuroprotective and memory enhancing effects in a rat model of Alzheimer’s disease

  2020cites this paper
• An Intensified Acrolein Exposure Can Affect Memory and Cognition in Rat

  2020cites this paper
• Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review

  2020cites this paper
• Exposure to Electromagnetic Field during Gestation Adversely Affects the Electrophysiological Properties of Purkinje Cells in Rat Offspring

  2020cites this paper
• Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease

  2020cites this paper
• G protein-coupled receptors in neurodegenerative diseases

  2020cites this paper
• Hyperexcitability of VTA dopaminergic neurons in male offspring exposed to physical or psychological prenatal stress.

  2020cites this paper
• The Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Possibly Through Inhibiting Oxidative Stress and ASK1-p38 Signaling

  2019cites this paper
• Modulation of sphingosine-1-phosphate receptor by FTY720 contributes in improvement of hepatic encephalopathy induced by bile duct ligation.

  2019cites this paper
• Bipolar disorder and the endocannabinoid system

  2019cites this paper
• Druggable Targets of the Endocannabinoid System: Implications for the Treatment of HIV-Associated Neurocognitive Disorder.

  2019cites this paper
• Kisspeptin-13 Improves Spatial Memory Consolidation and Retrieval against Amyloid-β Pathology

  2019cites this paper
• Exposure to Electromagnetic Field during Gestation Adversely Affects the Electrophysiological Properties of Purkinje Cells in Rat Offspring.

  2018cites this paper
• 2.45 GHz microwave radiation impairs learning, memory, and hippocampal synaptic plasticity in the rat

  2018cites this paper
• Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

  2018cites this paper
• Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer‐like symptoms in a transgenic animal model

  2018cites this paper
• Effect of Recombinant Insulin-like Growth Factor-2 Injected into the Hippocampus on Memory Impairment Following Hippocampal Intracerebral Hemorrhage in Rats

  2018cites this paper
• Effects and mechanisms of actions of phytochemicals on Alzheimer's disease neuropathology.

  2018cites this paper
• Early alteration of distribution and activity of hippocampal type‐1 cannabinoid receptor in Alzheimer's disease‐like mice overexpressing the human mutant amyloid precursor protein

  2018cites this paper
• Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System

  2018cites this paper
• Netrin-1 improves the amyloid-β-mediated suppression of memory and synaptic plasticity.

  2017cites this paper
• Synthetic Cannabinoids in Dementia

  2017cites this paper
• The effect of orexin-A on motor and cognitive functions in a rat model of Parkinson’s disease

  2017cites this paper
• Minocycline did not prevent the neurotoxic effects of amyloid β on intrinsic electrophysiological properties of hippocampal CA1 pyramidal neurons in a rat model of Alzheimer's disease

  2016influential citation
• Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.

  2016cites this paper
• Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

  2016cites this paper
• Alterations in the intrinsic electrophysiological properties of Purkinje neurons in a rat model of hepatic encephalopathy: Relative preventing effect of PPARγ agonist.

  2016cites this paper
• Streptozotocin Inhibits Electrophysiological Determinants of Excitatory and Inhibitory Synaptic Transmission in CA1 Pyramidal Neurons of Rat Hippocampal Slices: Reduction of These Effects by Edaravone

  2016cites this paper
• Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia.

  2016cites this paper
• Impaired Memory and Evidence of Histopathology in CA1 Pyramidal Neurons through Injection of Aβ1-42 Peptides into the Frontal Cortices of Rat

  2016cites this paper
• Maternal mobile phone exposure alters intrinsic electrophysiological properties of CA1 pyramidal neurons in rat offspring

  2016cites this paper
• Calcium channel blockade attenuates abnormal synaptic transmission in the dentate gyrus elicited by entorhinal amyloidopathy

  2016cites this paper
• New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds

  2015cites this paper
• Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline

  2015cites this paper
• Cellular and network mechanisms underlying memory impairment induced by amyloid β protein.

  2015cites this paper
• The therapeutic potential of berberine against the altered intrinsic properties of the CA1 neurons induced by Aβ neurotoxicity.

  2015cites this paper
• Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.

  2015cites this paper
• Alterations in CA1 pyramidal neuronal intrinsic excitability mediated by Ih channel currents in a rat model of amyloid beta pathology.

  2015influential citation
• Preventing Effect of L-Type Calcium Channel Blockade on Electrophysiological Alterations in Dentate Gyrus Granule Cells Induced by Entorhinal Amyloid Pathology

  2015cites this paper
• Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease

  2014cites this paper
• Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood–Brain Barrier

  2014cites this paper
• β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition.

  2014cites this paper
• Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

  2014cites this paper
• The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease

  2014cites this paper
• Impaired firing properties of dentate granule neurons in an Alzheimer's disease animal model are rescued by PPARγ agonism

  2014cites this paper
• Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system.

  2014cites this paper
• Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.

  2013influential citation
• Pharmacological blockade of TRPV1 receptors modulates the effects of 6‐OHDA on motor and cognitive functions in a rat model of Parkinson's disease

  2013cites this paper
• Hippocampus and cerebellum function following imipenem treatment in male and female rats: evaluation of sex differences during developmental stage.

  2013cites this paper
• Maternal mobile phone exposure adversely affects the electrophysiological properties of Purkinje neurons in rat offspring.

  2013cites this paper
• Electrical low frequency stimulation of the kindling site preserves the electrophysiological properties of the rat hippocampal CA1 pyramidal neurons from the destructive effects of amygdala kindling: the basis for a possible promising epilepsy therapy.

  2013cites this paper
• 2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents.

  2012cites this paper
• Date Fruit Extract Is a Neuroprotective Agent in Diabetic Peripheral Neuropathy in Streptozotocin-Induced Diabetic Rats: A Multimodal Analysis

  2011cites this paper
• See Blockindiscussions, Blockinstats, Blockinand Blockinauthor Blockinprofiles Blockinfor Blockinthis Blockinpublication the Blockinrole Blockinof Blockinendocannabinoid Blockinsignaling Blockinin Blockinthe Molecular Blockinmechanisms Blockinof Blockinneurodegeneration in Blockinalzheimer's Blockin

  year unknowninfluential citation
• Oral Thc: Cbd Cannabis Extract in Main Symptoms of Alzheimer Disease: Agitation and Weight Loss

  year unknowncites this paper